Ram Shankar Mani

Ram Shankar Mani

Auto-generated profile, based on publicly available information

Ram Shankar Mani

Department of Pathology, University of Texas Southwestern Medical Center, Dallas, Texas, USA

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 December 2008 in Science
Verified
Journal Article
Closed access
PDF file
Sooryanarayana VaramballySooryanarayana Varambally
Sooryanarayana Varambally
QCQi Cao
Qi Cao
RMRam-Shankar Mani
Ram-Shankar Mani
SSSunita Shankar
Sunita Shankar
XWXiaosong Wang
Xiaosong Wang
ACArul M. Chinnaiyan
Arul M. Chinnaiyan
Enhancer of zeste homolog 2 (EZH2) is a mammalian histone methyltransferase that contributes to the epigenetic silencing of target genes and regulates the survival and metastasis of cancer cells. EZH2 is overexpressed in aggressive solid tumors by mechanisms that remain unclear. Here we show that the expression and function of EZH2 in cancer cell lines are inhibited by microRNA-101 (miR-101). Analysis of human prostate tumors revealed that miR-101 expression decreases during cancer progression, paralleling an increase in EZH2 expression. One or both of the two genomic loci encoding miR-101 were somatically lost in 37.5% of clinically localized prostate cancer cells (6 of 16) and 66.7% of metastatic disease cells (22 of 33). We propose that the genomic loss of miR-101 in cancer leads to overexpression of EZH2 and concomitant dysregulation of epigenetic pathways, resulting in cancer progression.

1 May 2010 in Cancer Cell
Verified
Journal Article
Closed access
JYJindan Yu
Jindan Yu
JYJianjun Yu
Jianjun Yu
RMRam-Shankar Mani
Ram-Shankar Mani
QCQi Cao
Qi Cao
CBChad J. Brenner
Chad J. Brenner
ACArul M. Chinnaiyan
Arul M. Chinnaiyan

22 September 2008 in Oncogene
Verified
Journal Article
Open access
PDF file
QCQi Cao
Qi Cao
JYJ Yu
J Yu
SDS M Dhanasekaran
S M Dhanasekaran
JKJ H Kim
J H Kim
RMR-S Mani
R-S Mani
ACA M Chinnaiyan
A M Chinnaiyan
Enhancer of zeste homolog 2 (EZH2) is a critical component of the polycomb-repressive complex 2 (PRC2), which is involved in gene silencing and histone H3 lysine 27 methylation. EZH2 has a master regulatory function in controlling such processes as stem cell differentiation, cell proliferation, early embryogenesis and X chromosome inactivation. Although benign epithelial cells express very low levels of EZH2, increased levels of EZH2 have been observed in aggressive solid tumors such as those of the prostate, breast and bladder. The mechanism by which EZH2 mediates tumor aggressiveness is unclear. Here, we demonstrate that EZH2 mediates transcriptional silencing of the tumor suppressor gene E-cadherin by trimethylation of H3 lysine 27. Histone deacetylase inhibitors can prevent EZH2-mediated repression of E-cadherin and attenuate cell invasion, suggesting a possible mechanism that may be useful for the development of therapeutic treatments. Taken together, these observations provide a novel mechanism of E-cadherin regulation and establish a functional link between dysregulation of EZH2 and repression of E-cadherin during cancer progression.

27 November 2009 in Science
Verified
Journal Article
Closed access
PDF file
RMRam-Shankar Mani
Ram-Shankar Mani
STScott A. Tomlins
Scott A. Tomlins
KCKaitlin Callahan
Kaitlin Callahan
AGAparna Ghosh
Aparna Ghosh
MNMukesh K. Nyati
Mukesh K. Nyati
ACArul M. Chinnaiyan
Arul M. Chinnaiyan
Gene fusions play a critical role in cancer progression. The mechanisms underlying their genesis and cell type specificity are not well understood. About 50% of human prostate cancers display a gene fusion involving the 5′ untranslated region of TMPRSS2, an androgen-regulated gene, and the protein-coding sequences of ERG, which encodes an erythroblast transformation–specific (ETS) transcription factor. By studying human prostate cancer cells with fluorescence in situ hybridization, we show that androgen signaling induces proximity of the TMPRSS2 and ERG genomic loci, both located on chromosome 21q22.2. Subsequent exposure of the cells to gamma irradiation, which causes DNA double-strand breaks, facilitates the formation of the TMPRSS2-ERG gene fusion. These results may help explain why TMPRSS2-ERG fusions are restricted to the prostate, which is dependent on androgen signaling.

16 June 2020 in Nature Reviews Cancer
Verified
Journal Article
Open access
PDF file
JBJohann S. de Bono
Johann S. de Bono
CGChristina Guo
Christina Guo
BGBora Gurel
Bora Gurel
AMAngelo M. De Marzo
Angelo M. De Marzo
KSKaren S. Sfanos
Karen S. Sfanos
AAAndrea Alimonti
Andrea Alimonti
Prostate cancer is a major cause of cancer morbidity and mortality. Intra-prostatic inflammation is a risk factor for prostate carcinogenesis, with diet, chemical injury and an altered microbiome being causally implicated. Intra-prostatic inflammatory cell recruitment and expansion can ultimately promote DNA double-strand breaks and androgen receptor activation in prostate epithelial cells. The activation of the senescence-associated secretory phenotype fuels further ‘inflammatory storms’, with free radicals leading to further DNA damage. This drives the overexpression of DNA repair and tumour suppressor genes, rendering these genes susceptible to mutagenic insults, with carcinogenesis accelerated by germline DNA repair gene defects. We provide updates on recent advances in elucidating prostate carcinogenesis and explore novel therapeutic and prevention strategies harnessing these discoveries.

1 August 2011 in Cancer Cell
Verified
Journal Article
Closed access
QCQi Cao
Qi Cao
RMRam-Shankar Mani
Ram-Shankar Mani
BABushra Ateeq
Bushra Ateeq
SDSaravana M. Dhanasekaran
Saravana M. Dhanasekaran
IAIrfan A. Asangani
Irfan A. Asangani
ACArul M. Chinnaiyan
Arul M. Chinnaiyan